Welcome to our dedicated page for Option Care Health SEC filings (Ticker: OPCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Option Care Health, Inc. (OPCH) SEC filings page brings together the company’s official regulatory disclosures, as filed with the U.S. Securities and Exchange Commission. These documents provide detailed insight into how the nation’s largest independent provider of home and alternate site infusion services reports its financial condition, capital structure, governance changes and material agreements.
Investors can use this page to access current and historical 10-K and 10-Q reports, which contain audited and interim financial statements, segment information, risk factor discussions and management’s analysis of the business. For Option Care Health, these filings complement its earnings press releases that discuss net revenue, net income, earnings per share and non-GAAP measures such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS, and they provide the underlying GAAP detail and reconciliations referenced in those releases.
The page also tracks Form 8-K filings, which Option Care Health uses to report material events. Recent examples include 8-Ks furnishing quarterly earnings press releases under Item 2.02, an 8-K describing a Fourth Amendment to the company’s Amended and Restated First Lien Credit Agreement under Item 1.01 and Item 2.03, and an 8-K outlining a Chief Financial Officer transition and related compensatory arrangements under Item 5.02. These filings explain changes to term loans and revolving credit facilities, leadership appointments and transitions, and other significant corporate actions.
Users interested in executive and director information can review proxy materials and governance-related filings, which describe board composition, executive compensation structures and incentive plans referenced in 8-K disclosures. For those monitoring potential insider activity, Form 4 and related ownership reports, when filed, show transactions by directors, officers and significant shareholders in OPCH stock.
To make this information more accessible, this page pairs real-time updates from the SEC’s EDGAR system with AI-powered summaries that highlight key points from lengthy filings. Instead of reading an entire credit agreement amendment or multi-hundred-page annual report, users can quickly see what changed in Option Care Health’s debt terms, how non-GAAP metrics reconcile to GAAP results, or what new risks and governance details have been disclosed, and then drill into the full documents as needed.
Option Care Health Chief Medical Officer Femi Adewunmi reported a tax-withholding disposition of 1,396 shares of Common Stock on April 22, 2026 at $28.38 per share. After this automatic withholding to cover tax obligations, Adewunmi directly holds 25,314 shares of Option Care Health Common Stock.
Option Care Health is asking stockholders at its 2026 virtual annual meeting to elect nine directors, ratify KPMG as independent auditor for 2026, and approve executive compensation on an advisory basis.
For 2025, the company reports net revenue of $5,649.5 million, up 13.0%, net income of $207.6 million, adjusted EBITDA of $471.3 million (up 6.2%), and adjusted EPS of $1.72 (up 8.9%). Cash provided by operating activities was $258.4 million. Management notes more than 2.5 million infusion events for over 315,000 patients, supported by about 8,000 team members.
The proxy emphasizes governance features such as one-share/one-vote, an independent board chair, annual director elections, proxy access, and stockholder-called special meetings at 25% ownership. Executive pay is heavily performance-based, with more than 85% of target CEO compensation tied to financial and stock performance, using annual incentives and PSU/RSU grants under robust ownership and clawback policies.
Option Care Health, Inc. entered into a Fifth Amendment to its Amended and Restated First Lien Credit Agreement with Bank of America, N.A. as administrative agent. The amendment adds new revolving credit commitments totaling $450,000,000, structured as an increase to the existing Revolving Credit Commitments.
Following this change, the aggregate principal amount of Revolving Credit Commitments available under the credit agreement is $850,000,000. This amendment updates the company’s senior secured lending facility and represents additional committed borrowing capacity rather than an immediate borrowing.
Option Care Health Inc — The Vanguard Group filed Amendment No. 4 to a Schedule 13G/A reporting 0 shares beneficially owned (representing 0% of the class) following an internal realignment. The filing cites SEC Release No. 34-39538 and states certain subsidiaries will report separately. The filing is signed by Ashley Grim on 03/27/2026.
Option Care Health director Pate R. Carter reported an open-market sale of company stock. On February 27, 2026, Carter sold 30,287 shares of Option Care Health common stock at a weighted average price of $32.0474 per share in multiple trades, leaving 11,623 shares held directly.
Option Care Health, Inc. Chief Human Resources Officer Michael Bavaro reported an open-market sale of 6,000 shares of common stock at $33.00 per share. After this transaction, he directly owns 33,249 shares of Option Care Health common stock.
Option Care Health, Inc. Chief Operating Officer Luke Whitworth reported a tax-related share disposition. On this Form 4, he transferred 4,605 shares of common stock at $33.815 per share to cover tax withholding, rather than executing an open-market sale. After this transaction, he directly holds 169,589 common shares.
Option Care Health Chief Growth Officer reports tax-related share disposition
Christopher L. Grashoff, Chief Growth Officer of Option Care Health, Inc., disposed of 1,980 shares of common stock on a tax-withholding basis at $33.815 per share. After this tax-withholding disposition, he directly holds 44,092 Option Care Health common shares.